Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free MOTS Stock Alerts

Motus GI (MOTS) Competitors

Motus GI logo
$0.0001 0.00 (0.00%)
As of 09:41 AM Eastern
Compare

MOTS vs. AFIB, UTRS, DRTSW, ANZUW, and HSCSW

Should you buy Motus GI stock or one of its competitors? MarketBeat compares Motus GI with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Motus GI include Acutus Medical (AFIB), Minerva Surgical (UTRS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), and Heart Test Laboratories (HSCSW). These companies are all part of the "medical equipment" industry.

How does Motus GI compare to Acutus Medical?

Acutus Medical (NASDAQ:AFIB) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
Motus GI Neutral

Motus GI has lower revenue, but higher earnings than Acutus Medical. Motus GI is trading at a lower price-to-earnings ratio than Acutus Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
Motus GI$319K0.00-$12.87M-$14.69N/A

Motus GI has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Motus GI's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Motus GI N/A N/A N/A

Acutus Medical has a beta of 5.68, indicating that its stock price is 468% more volatile than the broader market. Comparatively, Motus GI has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 20.1% of Motus GI shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Comparatively, 0.3% of Motus GI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Acutus Medical and Motus GI tied by winning 5 of the 10 factors compared between the two stocks.

How does Motus GI compare to Minerva Surgical?

Motus GI (NASDAQ:MOTS) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

Motus GI has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.92, suggesting that its share price is 192% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Minerva Surgical N/A N/A N/A

Motus GI has higher earnings, but lower revenue than Minerva Surgical. Motus GI is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by company insiders. Comparatively, 8.5% of Minerva Surgical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Minerva Surgical Neutral

Summary

Minerva Surgical beats Motus GI on 4 of the 7 factors compared between the two stocks.

How does Motus GI compare to Alpha Tau Medical?

Motus GI (NASDAQ:MOTS) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

Alpha Tau Medical has lower revenue, but higher earnings than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Alpha Tau Medical had 3 more articles in the media than Motus GI. MarketBeat recorded 3 mentions for Alpha Tau Medical and 0 mentions for Motus GI. Alpha Tau Medical's average media sentiment score of 0.52 beat Motus GI's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Motus GI Neutral
Alpha Tau Medical Positive

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

Summary

Motus GI beats Alpha Tau Medical on 3 of the 5 factors compared between the two stocks.

How does Motus GI compare to Anzu Special Acquisition Corp I?

Motus GI (NASDAQ:MOTS) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

20.1% of Motus GI shares are owned by institutional investors. 0.3% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

In the previous week, Anzu Special Acquisition Corp I had 1 more articles in the media than Motus GI. MarketBeat recorded 1 mentions for Anzu Special Acquisition Corp I and 0 mentions for Motus GI. Anzu Special Acquisition Corp I's average media sentiment score of 0.87 beat Motus GI's score of 0.00 indicating that Anzu Special Acquisition Corp I is being referred to more favorably in the news media.

Company Overall Sentiment
Motus GI Neutral
Anzu Special Acquisition Corp I Positive

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Anzu Special Acquisition Corp I N/A N/A N/A

Summary

Motus GI beats Anzu Special Acquisition Corp I on 3 of the 5 factors compared between the two stocks.

How does Motus GI compare to Heart Test Laboratories?

Motus GI (NASDAQ:MOTS) and Heart Test Laboratories (NASDAQ:HSCSW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Heart Test Laboratories N/A N/A N/A

Heart Test Laboratories has lower revenue, but higher earnings than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Heart Test Laboratories$8.67KN/AN/AN/AN/A

In the previous week, Heart Test Laboratories had 2 more articles in the media than Motus GI. MarketBeat recorded 2 mentions for Heart Test Laboratories and 0 mentions for Motus GI. Heart Test Laboratories' average media sentiment score of 1.47 beat Motus GI's score of 0.00 indicating that Heart Test Laboratories is being referred to more favorably in the news media.

Company Overall Sentiment
Motus GI Neutral
Heart Test Laboratories Positive

20.1% of Motus GI shares are owned by institutional investors. 0.3% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Motus GI beats Heart Test Laboratories on 3 of the 5 factors compared between the two stocks.

Get Motus GI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MOTS vs. The Competition

Export
MetricMotus GISurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$44.83M$6.81B$12.57B
Dividend YieldN/A1.08%2.66%6.16%
P/E Ratio0.0020.1727.5225.33
Price / Sales0.0031.70539.41102.00
Price / CashN/A18.8748.5358.59
Price / Book0.008.3110.946.61
Net Income-$12.87M-$16.77M$3.57B$336.72M
7 Day PerformanceN/A8.98%2.69%2.63%
1 Month PerformanceN/A1.58%1.84%0.24%
1 Year PerformanceN/A-1.87%36.35%29.97%

Motus GI Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MOTS
Motus GI
N/A$0.00
flat		N/AN/A$1K$319KN/A30
AFIB
Acutus Medical
N/A$0.00
flat		N/AN/A$3K$7.16MN/A340
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A160
DRTSW
Alpha Tau Medical
N/A$1.84
-1.1%		N/A+1,375.0%$0.00N/AN/A80
ANZUW
Anzu Special Acquisition Corp I
N/A$0.03
+6.9%		N/A-3.1%$0.00N/AN/A2

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:MOTS) was last updated on 7/1/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel